Moreover, mGluR1 is expressed with high prevalence in most breast cancer subgroups, such as invasive breast cancer with positivity in 60% of the ductal tumors and 47% in lobular tumors and is an unfavorable prognostic marker (143, 144). The gene discussed is GRM1; the disease is breast carcinoma.